Your session is about to expire
← Back to Search
Dance Therapy for Parkinson's Disease
N/A
Waitlist Available
Led By Madeleine E. Hackney, PhD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial is testing whether dance can help improve brain function in people with Parkinson's disease.
Who is the study for?
This trial is for people aged 40-70 with Parkinson's Disease who can walk at least 10 feet with or without help. They must have decent vision, no dementia or memory issues, and be willing to spend an hour in a scanner. Those with brain implants, metal in their body, severe hearing loss, nerve damage, untreated depression, or past strokes/TBI cannot join.Check my eligibility
What is being tested?
The study is examining how adapted tango dancing versus a behavioral control condition affects brain activity in individuals with and without Parkinson's Disease. Participants will undergo testing at the Atlanta VA Medical Center and Emory University over five years.See study design
What are the potential side effects?
While not explicitly stated for this trial, common side effects from physical activities like dance may include muscle soreness, fatigue, and risk of falls especially relevant to those with PD.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Connectivity strength
Percent signal change
Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Internal guidance training (IG)Experimental Treatment1 Intervention
Adapted tango dancing is a sophisticated, yet accessible system of tactile communication that conveys motor intentions and goals between a leader and follower. Those in IG training will choose direction, timing and amplitude of each successive step, and will communicate this information to their partner through moving their frame and center of mass.
Group II: Externally guided training (EG)Experimental Treatment1 Intervention
Those in EG will learn to attend to sensory cues for movement direction, timing and amplitude of steps, communicated from their partner to them via the frame and center of mass. The 'follower' will wait to receive the movement cue before moving.
Group III: Behavioral Control (BC)Active Control1 Intervention
BC participants will attend group health education sessions adapted to the needs of individuals with PD, about pharmacological management, nutrition, sleep disorders, cognitive deficits, bereavement coping, mobility, balance and home safety. Participants in this training will be instructed not to change their habitual exercise routines. After completing health education, participants will be assigned to an IG or EG training class but will not undergo evaluations.
Group IV: Normal Control (NC)Active Control1 Intervention
Age-matched controls without Parkinson's disease will come in for a single assessment including MRI.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,609 Previous Clinical Trials
3,306,492 Total Patients Enrolled
Madeleine E. Hackney, PhDPrincipal InvestigatorAtlanta VA Medical and Rehab Center, Decatur, GA
2 Previous Clinical Trials
273 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You can walk at least 10 feet with or without help.You have a deep brain stimulator, metal implants, fragments, or a pacemaker.Your Montreal Cognitive Assessment (MoCA) score is less than 24.Your ability to hear quiet sounds is worse than 40 decibels.You have nerve problems in your arms or legs.You have not received treatment for severe depression.You have had a stroke or a serious head injury in the past.You must be between 40 and 70 years old.You are willing to spend 1 hour inside a scanner.Your vision with glasses or contacts is better than 20/70 in your better eye.You do not have dementia or memory problems caused by blood vessel issues in the brain.You do not have major problems with remembering things.
Research Study Groups:
This trial has the following groups:- Group 1: Internal guidance training (IG)
- Group 2: Externally guided training (EG)
- Group 3: Behavioral Control (BC)
- Group 4: Normal Control (NC)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts currently underway for this experiment?
"According to the details on clinicaltrials.gov, this research endeavour is not presently enlisting applicants as it was last updated on January 21st 2022. Although there are no longer any openings for this trial, 490 other trials are actively searching for participants at present."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger